2022
DOI: 10.2217/bmm-2022-0499
|View full text |Cite
|
Sign up to set email alerts
|

Serum Circulating Free Dna of Syncytin-1 As A Novel Molecular Marker for Early Diagnosis of Non-Small-Cell Lung Cancer

Abstract: Background: Liquid biopsy has been receiving attention as an emerging detection technology in the clinical application of non-small-cell lung cancer (NSCLC). Methods: We quantified serum circulating free DNA (cfDNA) of syncytin-1 in 126 patients and 106 controls, analyzed the correlation of level with pathological parameters and explored diagnostic utility. Results: The cfDNA of syncytin-1 levels in NSCLC patients were higher than healthy controls (p < 0.0001). These levels were associated with smoking hist… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…In non-small cell lung cancer (NSCLC), the syncytin-1 gene is increased expression due to chromosome activation and nucleosome depolymerization. Thus, the circulating free DNA of syncytin-1 is increased in the serum of NSCLC patients [ 124 ]. And the expression of syncytin-1 was significantly higher in NSCLC tissues than in para-carcinoma tissues.…”
Section: Syncytin-1 and Tumorsmentioning
confidence: 99%
“…In non-small cell lung cancer (NSCLC), the syncytin-1 gene is increased expression due to chromosome activation and nucleosome depolymerization. Thus, the circulating free DNA of syncytin-1 is increased in the serum of NSCLC patients [ 124 ]. And the expression of syncytin-1 was significantly higher in NSCLC tissues than in para-carcinoma tissues.…”
Section: Syncytin-1 and Tumorsmentioning
confidence: 99%